title: Comment: evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome.
authors.forename: Scott N
authors.initials: SN
authors.lastname: Lucyk
authors.forename: Benjamin
authors.initials: B
authors.lastname: Wadowski
authors.forename: Edward
authors.initials: E
authors.lastname: Qian
authors.forename: Daniel
authors.initials: D
authors.lastname: Lugassy
authors.forename: Robert S
authors.initials: RS
authors.lastname: Hoffman
mesh_terms: D001569:Benzodiazepines / Q000627:therapeutic use*; D000431:Ethanol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007649:Ketamine / Q000627:therapeutic use*; D008297:Male; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
chemical_list: D016194:Receptors, N-Methyl-D-Aspartate; D001569:Benzodiazepines; D000431:Ethanol; D007649:Ketamine